Related Experiment Video

Updated: Aug 18, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Cholesterol lowering in diabetes. New evidence supports aggressive LDL-C targets

Robert S Rosenson

    Postgraduate Medicine
    |April 22, 2005
    PubMed

    Insights

    Patients with diabetes have a high risk of coronary heart disease (CHD). Aggressively lowering low-density lipoprotein cholesterol (LDL-C) is crucial. This review covers cholesterol management strategies, including statin therapy, for diabetic patients.

    Area of Science:

    • Cardiology
    • Endocrinology
    • Metabolic Disorders

    Background:

    • Diabetes mellitus is recognized as a coronary heart disease (CHD) equivalent.
    • Aggressive management of modifiable risk factors is recommended for diabetic patients.
    • Plasma low-density lipoprotein cholesterol (LDL-C) is a key modifiable risk factor.

    Purpose of the Study:

    • To discuss the rationale for cholesterol lowering in patients with diabetes.
    • To review lipoprotein abnormalities associated with insulin resistance.
    • To explore the prognostic significance of elevated LDL particle numbers and current treatment strategies.

    Main Methods:

    • Review of recent guidelines for diabetes and CHD management.
    • Discussion of lipoprotein metabolism in insulin resistance.
    • Analysis of findings from recent clinical trials on lipid-lowering therapies.

    Main Results:

    • High LDL particle numbers are significant in predicting cardiovascular risk in diabetic patients.
    • Statin therapy is a primary strategy for lowering LDL-C in this population.
    • Other treatment strategies for lipoprotein management are also highlighted.

    Conclusions:

    • Cholesterol lowering is essential for managing cardiovascular risk in patients with diabetes.
    • Understanding lipoprotein abnormalities in insulin resistance guides treatment decisions.
    • Evidence from clinical trials supports the use of statins and other agents to improve lipid profiles and reduce CHD risk in diabetic individuals.

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Lipids: Dietary Sources and Requirements01:18

    Lipids: Dietary Sources and Requirements

    Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...